Dr. James K. Aikins Jr., MD

Dr. Aikins practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Dr. Aikins' NPI, 1346337839, was assigned on October 6, 2006. Dr. Aikins graduated from MCP-Hahnemann College of Medicine in 1985. Dr. Aikins holds New Jersey license MA52482.

Dr. Aikins' primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Dr. Aikins also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Dr. Aikins' primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. Dr. Aikins is also affiliated with Robert Wood Johnson University Hospital Hamilton. The medical group on file is Rutgers-RWJ Scleroderma Program. Dmand AI also links Dr. Aikins to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aikins practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Aikins' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Aikins is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Aikins' licenses on file in 2 states: New Jersey and Pennsylvania.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Aikins treats.

CMS data shows 113 Medicare services from Dr. Aikins across 3 procedure codes in 2024, all of them office visits, for 66 Medicare patients. Medicare paid $8,443 for them.

CMS counts 66 Medicare patients who saw Dr. Aikins in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Aikins' median patient age at 67, with 97% women.

In 2024, Dr. Aikins wrote 77 Medicare Part D claims for 33 patients. 82% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $341 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Aikins for performance year 2024, reported as part of a group. Dr. Aikins accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Aikins, published from 2008 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Antineoplastic Agents, Ovarian Neoplasms and Epigenesis, Genetic. Dr. Aikins has published most often in Gynecol Oncol. Dr. Aikins' most frequent co-authors are Michelle Cifone Bilbao, DO, Olga Ostrovsky, MD and Jerome H. Check, MD, PhD.

CMS Open Payments shows 30 general payments to Dr. Aikins from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Pacira Pharmaceuticals Incorporated paid the most, $216.

Dmand AI lists 3 awards for Dr. Aikins, most recently CMS Stage 1 EHR in 2013.

Dr. Aikins graduated from MCP-Hahnemann College of Medicine in 1985. Dr. Aikins is a member of ACS and ASCO.

Dr. Aikins is in network with 18 carriers, including Elevance, Aetna and Horizon Blue Cross Blue Shield of New Jersey. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.